Literature DB >> 27856217

Response to: Comment to "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease".

Giulio Marchesini1, Michael Roden2, Roberto Vettor3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27856217     DOI： 10.1016/j.jhep.2016.11.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Prognostic value of non-alcoholic fatty liver disease in the elderly patients.

Authors:  Viola Tallarico; Guerino Recinella; Donatella Magalotti; Antonio Muscari; Marco Zoli; Giampaolo Bianchi
Journal:  Aging Clin Exp Res       Date:  2020-02-01       Impact factor: 3.636

Review 2.  Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Ecaterina Neculae; Claudia Florida Costea; Manuela Ciocoiu; Loredana Liliana Hurjui; Claudia Cristina Tarniceriu; Mariana Floria
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

3.  BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE?

Authors:  Marcos Bertozzi Goldoni; Paulo Roberto Ott Fontes; Marcela Menuci GuimarÃes; João Alfredo Diedrich-Neto; Tiele Nogueira; Uirá Fernandes Teixeira; Caroline Becker Giacomazzi; Guillermo Kiss; Sérgio Ricardo Pioner; Pablo Duarte Rodrigues
Journal:  Arq Bras Cir Dig       Date:  2021-01-15

Review 4.  The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Claudia Florida Costea; Manuela Ciocoiu; Cristina Mihaela Lacatusu; Minela Aida Maranduca; Anca Ouatu; Mariana Floria
Journal:  J Diabetes Res       Date:  2020-07-31       Impact factor: 4.011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.